Parker M, Mohankumar KM, Punchihewa C et al (2014) C11orf95-RELA fusions drive oncogenic NF-κB signalling in ependymoma. Nature 506(7489):451–455

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pajtler KW, Witt H, Sill M et al (2015) Molecular classification of ependymal tumors across All CNS 2 compartments, histopathological grades, and age groups. Cancer Cell 27(5):728–743

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tomomasa R, Arai Y, Kawabata-Iwakawa R et al (2021) Ependymoma-like tumor with mesenchymal differentiation harboring C11orf95-NCOA1/2 or -RELA fusion: a hitherto unclassified tumor related to ependymoma. Brain Pathol 31(3):e12943

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dorwal P, White C, Goh AF et al (2023) Ependymoma-like tumor with mesenchymal differentiation (ELTMD) with ZFTA:NCOA1 fusion: a diagnostic challenge. Neuropathology. https://doi.org/10.1111/neup.12952

Article  PubMed  Google Scholar 

Nobusawa S, Yokoo H, Hirato J et al (2012) Analysis of chromosome 19q13.42 amplification in embryonal brain tumors with ependymoblastic multilayered rosettes. Brain Pathol 22(5):689–697

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nobusawa S, Hirato J, Sugai T et al (2016) Atypical teratoid/rhabdoid Tumor (AT/RT) arising from ependymoma: a type of AT/RT secondarily developing from other primary central nervous system tumors. J Neuropathol Exp Neurol 75(2):167–174

Article  CAS  PubMed  Google Scholar 

Sumegi J, Streblow R, Frayer RW et al (2010) Recurrent t(2;2) and t(2;8) translocations in rhabdomyosarcoma without the canonical PAX-FOXO1 fuse PAX3 to members of the nuclear receptor transcriptional coactivator family. Genes Chromosom Cancer 49(3):224–236

Article  CAS  PubMed  Google Scholar 

Capper D, Jones DTW, Sill M et al (2018) DNA methylation-based classification of central nervous system tumours. Nature 555(7697):469–474

Article  CAS  PubMed  PubMed Central  Google Scholar 

Capper D, Stichel D, Sahm F et al (2018) Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience. Acta Neuropathol 136(2):181–210

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pietsch T, Wohlers I, Goschzik T et al (2014) Supratentorial ependymomas of childhood carry C11orf95-RELA fusions leading to pathological activation of the NF-κB signaling pathway. Acta Neuropathol 127(4):609–611

Article  PubMed  Google Scholar 

Ellison DW, Aldape KD, Capper D et al (2020) cIMPACT-NOW update 7: advancing the molecular classification of ependymal tumors. Brain Pathol. 30(5):863–866

Article  PubMed  PubMed Central  Google Scholar 

Mahajan S, Nambirajan A, Sharma A et al (2021) Ependymosarcoma harboring C11orf95:RELA fusion transcript: report of two cases and review of the literature. Neuropathology 41(5):412–421

Article  PubMed  Google Scholar 

Wu KS, Sung SY, Huang MH et al (2022) Clinical and molecular features in medulloblastomas subtypes in children in a cohort in Taiwan. Cancers. 14(21):5419

Article  CAS  PubMed  PubMed Central  Google Scholar 

Polivka J, Svajdler M, Priban V et al (2022) Oncogenic fusions in gliomas: an institutional experience. Anticancer Res 42(4):1933–1939

Article  CAS  PubMed  Google Scholar 

Cachia D, Wani K, Penas-Prado M et al (2015) C11orf95-RELA fusion present in a primary supratentorial ependymoma and recurrent sarcoma. Brain Tumor Pathol 32(2):105–111

Article  CAS  PubMed  Google Scholar 

Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23(8):1231–1251

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li FP, Fraumeni JF Jr, Mulvihill JJ et al (1988) A cancer family syndrome in twenty-four kindreds. Can Res 48(18):5358–5362

CAS  Google Scholar 

Bougeard G, Renaux-Petel M, Flaman JM et al (2015) Revisiting Li-Fraumeni syndrome from TP53 mutation carriers. J Clin Oncol 33(21):2345–2352

Article  CAS  PubMed  Google Scholar